Can the carbon dioxide laser completely ablate basal cell carcinomas? A histological study

Area of Science:

• Dermatology
• Oncology
• Laser Surgery

Background:

• Basal cell carcinoma (BCC) is the most common type of skin cancer.
• Carbon dioxide (CO2) laser ablation is explored as a therapeutic option for BCC.
• Understanding the limitations of CO2 laser ablation is crucial for effective treatment.

Purpose of the Study:

• To evaluate the efficacy and limitations of CO2 laser ablation for basal cell carcinoma.
• To determine the relationship between ablation depth, tumor type, and complete tumor removal.
• To identify patient and tumor characteristics that predict successful CO2 laser ablation outcomes.

Main Methods:

• Fifty-one BCCs (4-35 mm) were treated with CO2 laser ablation using a microprocessor-controlled flash scanner.
• Tumor beds were histologically examined post-ablation to assess complete tumor removal.
• Ablation depth and tumor type (superficial, nodular, infiltrative) were correlated with treatment outcomes.

Main Results:

• Complete ablation at the deep margin was significantly associated with ablation depth (P=0.006) and tumor type (P=0.01).
• Superficial BCCs, especially on the trunk, were reliably ablated to the mid-dermis or deeper.
• Nodular BCCs were not reliably ablated; smaller ones (<10 mm) required deeper ablation, risking scarring.

Conclusions:

• CO2 laser ablation is a fast modality suitable for specific BCCs when strict selection criteria are applied.
• This method is most beneficial for patients with multiple superficial BCCs.
• Careful consideration of ablation depth is necessary to balance efficacy and potential side effects like delayed healing and scarring.